U.S. Physical Therapy Croissance future
Future contrôle des critères 3/6
U.S. Physical Therapy devrait augmenter ses bénéfices et ses revenus de 47.5% et de 7.3% par an respectivement, tandis que le BPA devrait croître de croître de 52.4% par an.
Informations clés
47.5%
Taux de croissance des bénéfices
52.36%
Taux de croissance du BPA
| Healthcare croissance des bénéfices | 18.4% |
| Taux de croissance des recettes | 7.3% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Good |
| Dernière mise à jour | 21 May 2026 |
Mises à jour récentes de la croissance future
Recent updates
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaThese 4 Measures Indicate That U.S. Physical Therapy (NYSE:USPH) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Pinning Down U.S. Physical Therapy, Inc.'s (NYSE:USPH) P/E Is Difficult Right Now
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...U.S. Physical Therapy (NYSE:USPH) Is Reinvesting At Lower Rates Of Return
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Here's Why U.S. Physical Therapy (NYSE:USPH) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year
Key Insights U.S. Physical Therapy's Annual General Meeting to take place on 20th of May CEO Chris Reading's total...Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
U.S. Physical Therapy, Inc. ( NYSE:USPH ), might not be a large cap stock, but it received a lot of attention from a...U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion
Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
The market for U.S. Physical Therapy, Inc.'s ( NYSE:USPH ) shares didn't move much after it posted weak earnings...U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
The board of U.S. Physical Therapy, Inc. ( NYSE:USPH ) has announced that it will pay a dividend of $0.44 per share on...Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Key Insights Using the 2 Stage Free Cash Flow to Equity, U.S. Physical Therapy fair value estimate is US$113 U.S...Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not be the most widely known stock at the moment, it saw a...U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations
Summary USPH has a substantial presence in the physical therapy industry, with 662 clinics in 41 states, particularly Texas and Tennessee. Acquisitions, primarily through partnership models, are central to USPH's growth strategy. The company expanded into the IIP sector in 2017 and has made several acquisitions. The U.S. rehab market is projected to exceed $40 billion by 2025, driven by demographic trends like an aging population, rising obesity, and a focus on cost-effective healthcare. Physical therapy has demonstratedcost-effectiveness in patient care, significantly reducing hospitalization ratesand total treatment costs. USPH's current stock valuepresents a favorable entry point, especially with market misconceptions aboutGLP-1 adoption impacting the physical therapy industry. Read the full article on Seeking AlphaIs U.S. Physical Therapy (NYSE:USPH) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 981 | 56 | N/A | N/A | 1 |
| 12/31/2027 | 896 | 72 | 83 | 108 | 7 |
| 12/31/2026 | 839 | 57 | 68 | 92 | 7 |
| 3/31/2026 | 788 | 8 | 67 | 84 | N/A |
| 12/31/2025 | 773 | 22 | 61 | 75 | N/A |
| 9/30/2025 | 751 | 36 | 57 | 70 | N/A |
| 6/30/2025 | 722 | 35 | 61 | 72 | N/A |
| 3/31/2025 | 692 | 33 | 56 | 66 | N/A |
| 12/31/2024 | 664 | 28 | 66 | 75 | N/A |
| 9/30/2024 | 639 | 14 | 73 | 82 | N/A |
| 6/30/2024 | 621 | 16 | 68 | 77 | N/A |
| 3/31/2024 | 606 | 18 | 66 | 75 | N/A |
| 12/31/2023 | 599 | 18 | 73 | 82 | N/A |
| 9/30/2023 | 585 | 24 | 64 | 72 | N/A |
| 6/30/2023 | 575 | 26 | 62 | 70 | N/A |
| 3/31/2023 | 564 | 28 | 50 | 58 | N/A |
| 12/31/2022 | 548 | 29 | 50 | 59 | N/A |
| 9/30/2022 | 536 | 39 | 48 | 57 | N/A |
| 6/30/2022 | 522 | 38 | 59 | 68 | N/A |
| 3/31/2022 | 509 | 37 | 61 | 70 | N/A |
| 12/31/2021 | 490 | 31 | 68 | 76 | N/A |
| 9/30/2021 | 477 | 31 | 78 | 86 | N/A |
| 6/30/2021 | 461 | 30 | 81 | 87 | N/A |
| 3/31/2021 | 418 | 32 | 95 | 101 | N/A |
| 12/31/2020 | 418 | 32 | 92 | 100 | N/A |
| 9/30/2020 | 423 | 30 | 82 | 91 | N/A |
| 6/30/2020 | 431 | 31 | 72 | 82 | N/A |
| 3/31/2020 | 473 | 29 | 55 | 65 | N/A |
| 12/31/2019 | 477 | 31 | N/A | 62 | N/A |
| 9/30/2019 | 472 | 30 | N/A | 65 | N/A |
| 6/30/2019 | 468 | 23 | N/A | 71 | N/A |
| 3/31/2019 | 457 | 18 | N/A | 71 | N/A |
| 12/31/2018 | 449 | 17 | N/A | 73 | N/A |
| 9/30/2018 | 442 | 18 | N/A | 70 | N/A |
| 6/30/2018 | 432 | 22 | N/A | 65 | N/A |
| 3/31/2018 | 421 | 21 | N/A | 58 | N/A |
| 12/31/2017 | 410 | 22 | N/A | 57 | N/A |
| 9/30/2017 | 392 | 20 | N/A | 53 | N/A |
| 6/30/2017 | 377 | 20 | N/A | 42 | N/A |
| 3/31/2017 | 363 | 21 | N/A | 51 | N/A |
| 12/31/2016 | 353 | 21 | N/A | 51 | N/A |
| 9/30/2016 | 348 | 20 | N/A | 48 | N/A |
| 6/30/2016 | 344 | 21 | N/A | 49 | N/A |
| 3/31/2016 | 337 | 21 | N/A | 49 | N/A |
| 12/31/2015 | 327 | 21 | N/A | 38 | N/A |
| 9/30/2015 | 320 | 21 | N/A | 45 | N/A |
| 6/30/2015 | 313 | 20 | N/A | 43 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de USPH ( 47.5% par an) est supérieure au taux d'épargne ( 3.5% ).
Bénéfices vs marché: Les bénéfices de USPH ( 47.5% par an) devraient croître plus rapidement que le marché US ( 16.8% par an).
Croissance élevée des bénéfices: Les bénéfices de USPH devraient augmenter de manière significative au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de USPH ( 7.3% par an) devrait croître plus lentement que le marché de US ( 11.7% par an).
Croissance élevée des revenus: Le chiffre d'affaires de USPH ( 7.3% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de USPH devrait être élevé dans 3 ans
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/22 10:50 |
| Cours de l'action en fin de journée | 2026/05/22 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
U.S. Physical Therapy, Inc. est couverte par 15 analystes. 7 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Joseph France | Cantor Fitzgerald & Co. |